Overview

Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This will be an open-label, fixed-sequence, multiple dose crossover study in 14 healthy male and/or female subjects, to estimate the effect of steady state lersivirine on the steady state pharmacokinetics of abacavir/lamivudine.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Collaborator:
ViiV Healthcare
Treatments:
Abacavir
Dideoxynucleosides
Lamivudine